Roche Palo Alto LLC v. Ranbaxy Laboratories Ltd.

OPINION

WOLFSON, District Judge.

Presently before the Court is the Motion of Defendants, Ranbaxy Laboratories Limited and Ranbaxy Inc., (collectively referred to as “Ranbaxy”), for Summary Judgment of Invalidity for Improper In-ventorship on Plaintiff Roche Palo Alto LLC (“Roehe”)’s United States Patent, No. 6,083,953 (the “953 Patent”). Ranbaxy argues that the '953 Patent is invalid because the patent originally issued with improper inventorship and was not corrected until a Certificate of Correction was obtained after the commencement of this litigation. The parties disagree whether the…